That is essential, due to the fact that the way a protein in the body folds figures out if a pharmaceutical will be able to bind to that protein and be reliable. In other words, we have to know how these proteins fold if we want a drug to work. Historically, this has actually been a trial-and-error process (last week). And now, Alpha, Fold can predict protein folding with 92. 4% precision. That's going to make it much simpler to develop drugs that do what they're developed to do. This was a breakthrough almost nobody observed. But it's going to have extensive ramifications for curing disease. I anticipate that Alpha, Fold will be 98% accurate by the end of 2021.
And, of course, there will be a lot of financial investment chances in this area, too. Shifting subjects It's going to be an excellent year for bitcoin. I'm bullish on it in 2021 (jeff brown top biotech stock 2021). That said, I still think bitcoin will continue to be volatile. We're close to all-time highs. I wouldn't be shocked if it pulled back maybe substantially prior to going higher - jeff brown genome sequencing stock. I've been covering bitcoin for a long period of time now. One of the first research reports I ever published was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that initial suggestion, I entitled my report "What's the Big Deal With Bitcoin?" That reveals you where the conversation was at the time. We were mainly informing readers. However that's not the huge concern any longer. Now we're seeing institutional cash finally take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, specific niche enterprise. Mass, Mutual is a relied on 170-year-old institution. So consider that. In five years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
Which's a big reason I'm bullish on it this year. biotech stocks. Regards, Jeff Brown, Editor, The Bleeding Edge I have a benefit forecast 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than 20 years. These companies raised an overall of $172 billion. That's an all-time high beating the previous annual record by 43%. I forecast 2021 will be another record year in IPOs. There are a lot of fantastic personal business on the edge of striking the general public markets And I have actually been working on a brand-new way for you to invest even prior to these companies go public.
This opportunity has been developing over the last couple of years. I can't wait to tell you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Occasion to find out all the details. Go right here to book your spot totally free.
Emma Walsh here, handling editor of the Journal. Routine Journal readers know that tech isn't our usual beat (brownstone research). And when it comes to tech investing, we leave it to the professionals. Fortunately, we have several such specialists in our Rolodex. Our associate Jeff Brown will recognize to our long time readers. He is among the most accomplished tech investing experts we understand (jeff brown 2020 predictions). In truth, he had several triple-digit returns in his Brownstone Research study portfolios in 2015. Here's what Jeff thinks the tech sector will bring us in 2021 Each year, I like to have a look at the huge picture and forecast what's just around the corner.
That includes things like 5G networks, biotech, expert system, and a lot more. These trends are experiencing exponential development and creating extraordinary chances for investors. I wish to make sure all our readers are gotten ready for what's next. And with that in mind, let me draw the picture of what I see coming in the next 12 months Our brand-new 5G (fifth-generation) wireless networks are a subject I've been covering for years now. last year. However in spite of what many readers may think, this is a pattern that's just beginning. Although the COVID-19 pandemic disrupted supply chains last year, a remarkable 250 million 5G-enabled gadgets were still offered.
And all of this eventually resulted in Apple postponing the release of the 5G-enabled i, Phone 12 by 2 months (jeff brown 2021 stock predictions). Losing 2 months of production and sales really impacts the number of 5G gadgets are sold in the calendar year. When you consider all of that, selling 250 million units is exceptional. More significantly, the delays triggered by the pandemic developed a lots of suppressed need. And that need is now going to be pressed into 2021. In truth, I predict that more than 500 million 5G gadgets will be delivered in 2021 - united arab emirates. And that's not my only 5G forecast When I've spoken about 5G in the past, I've described its three various stages.
In Phase 2, 5G gadgets go on sale. 5G phones and other products begin to reach consumers. And in Phase Three, 5G services start to be provided (jeff bezos). That's when we start to see applications running on 5G networks. Think about things like enormous multiplayer games over a cellphone. That's not possible with 4G. It will be with 5G. And my 2nd 5G forecast for 2021 is that we will begin Stage 3 by this summer season. This starts something of a virtuous cycle: The majority of people do not really care about the innovation. However they will care if there are amazing applications that can just be accessed with a 5G phone.
That leads to more 5G apps being established. In reality, 5G is going to open a suite of incredible applications: self-driving automobiles, the Web of Things, robotic surgical treatment, and more. All of these innovations need 5G. The financial investment chances moving forward will be enormous. Stepping far from 5G, the next important technology I predict in 2021 is CRISPR hereditary editing. CRISPR represents "clustered routinely interspaced short palindromic repeat." It's a mouthful. However it is among the most amazing advancements in biotechnology. At a high level, CRISPR is a technology that can edit our genetic makeup as if it were software application.
The program can crash or not function correctly. CRISPR utilizes a comparable idea however with our hereditary code. "Typos" in our genome can cause illness. CRISPR can fix these "typos." For many years, CRISPR was mostly a niche technology that wasn't well understood. And throughout that time, there were truly only 3 business operating in this area. However things are altering. CRISPR is no longer simply theoretical. We're seeing real outcomes. We're dealing with illness and seeing that this technology just works. And as a result, a "2nd crop" of early-stage CRISPR business is going public and providing extraordinary returns. This whole industry is effectively a greenfield opportunity.
There's space for many business to exist in this area. united states. And there will be more. That's my prediction for CRISPR in 2021. I predict that 2 or three more genetic editing companies will hold their IPOs. Sticking with biotechnology, we are seeing amazing things happening at the merging of biotech and synthetic intelligence (AI). Google's AI subsidiary, Deep, Mind, just announced at the end of 2020 that its most current Alpha, Fold software application can precisely predict the folding of a protein based entirely on its amino acid series with 92. 4% accuracy. That is essential due to the fact that the way a protein in the human body folds identifies if a pharmaceutical will be able to bind to that protein and work.
Historically, this has been an experimental process. Now, Alpha, Fold can anticipate protein folding with 92. 4% accuracy. That's going to make it a lot easier to develop drugs that do what they're designed to do. And here's my next prediction. I forecast that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not simply one but several drug treatments produced utilizing this innovation. This was among those advancements that practically nobody saw. However it's going to have extensive ramifications for curing illness. And, of course, there will be a lot of investment opportunities in this area, too.
It's going to be a great year for bitcoin. I'm bullish on it in 2021. That said, I still believe bitcoin will continue to be volatile. We're close to all-time highs. I wouldn't be amazed if it drew back possibly substantially before going higher. I have actually been covering bitcoin for a very long time now. One of the first research reports I ever published was on bitcoin - jeff brown 2021 stock picks. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for anybody who followed my suggestion. However at the time of that preliminary suggestion, I titled my report, "What's the Big Offer With Bitcoin?" That shows you where the discussion was at the time.
However no one is asking that concern any longer. Now, we're seeing institutional cash lastly taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, specific niche enterprise. jeff brown predictions for 2021. Mass, Mutual is a 150-year-old organization. So believe about that. In 5 years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a big reason why I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more benefit forecast In 2021, we're going to have another record year in IPOs. One website reports that Jeff Brown is worth about $27. 5 million and claims the information depends on date since February 2021, however we could not independently verify this claim. Offered Jeff Brown's past, he likely has a significant net worth, but we can't hammer down an exact figure at this minute. Brown is best known for his sage-like capability to choose winning technology stocks. He invested more than 25 years researching technology companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's substantial experience provides him an exceptional point of view on the market. He's always on the hunt for brand-new chances, and he shares much of his finest choices in the Future Report.
That's full marks, however it's not ridiculously reasoned. Brown has an outstanding track record as a stock-picker, and he effectively predicted some of the most significant economic occasions of the previous twenty years. Although he doesn't appear to release his picks to the public, the service's success is a direct indication of Brown's stock-picking expertise. No one on Wall Street gets it ideal whenever, however Jeff Brown's accurate forecasts have made him legions of devoted fans. That says a lot about his capability. The Future Report is released by Brownstone Research study, a prominent financial research study publisher. Brownstone Research provides several research services with a wide range of expertises - jeff brown latest prediction.
The business is also associated with Bonner & Partners, another well-respected research publisher - jeff brown genome sequencing. On its site, Brownstone says its mission is to supply retail financiers with professional-grade research study: "For too long, the finest financial investment research has actually not been available to private financiers. It has been usually reserved for financial investment banks, hedge funds, private equity, and high-net-worth customers. jeff brown stock picks 2021. The mission of Brownstone Research is to make that sort of proprietary research available to any financiers aiming to gain an edge in the marketplaces. The objective is simple to deliver unique and rewarding financial investment research study discovered no place else." -Brownstone Research site excerpt from the Jeff Brown is the founder of Brownstone Research, and he also functions as the company's Chief Financial investment Expert.
With Brown guiding the ship, Brownstone Research study is a powerhouse publisher with lots to use its customers. After years of consistent success at the helm of top-tier companies like Tesla and Area, X, Elon Musk is a family name throughout the majority of America. If you know even a bit about the market, you understand that he has a credibility as a King Midas of sorts. jeff brown biotech pick. Everything he touches turns to gold! Jeff is well mindful of Elon Musk's executive prowess, so he always has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next big job.
In fact, Brown believes S.A.V. jeff brown top biotech 2020. might be "the biggest trend of the 2020s, and he's not alone. Take a look at these quotes from other well-known S.A.V. bulls: Elon's next big act will be weding 2 innovative innovations: artificial intelligence and electrical vehicles. Musk hopes the mix will assist him establish the very first fully-autonomous, self-driving automobiles ever. It's absolutely nothing brief of the automobile industry's Holy Grail. As you know, electrical vehicles and self-driving automobile stocks have actually been big this year, however the Wall Street device has been huge on buzz without much concrete outcome. Despite an extreme increase in competition over the past few years, Brown still believes Musk has the very best chance of putting all of it together.
tech could be the magic string that ties everything together. S.A.V. stands for Shared Autonomous Vehicle, and it might be the future of transportation. Essentially, this innovation would enable you to rent your automobile as a self-governing, self-driving taxi when you're not using it. You just get out of the automobile and press a button on an app that informs the cars and truck to "join the fleet." Next thing you know, you're relaxing on your sofa while your automobile shuttles ride-sharers around town. Best of all, you get to keep a large chunk of the revenues. It sounds insane, but it could be closed than you think.